MyPeBS is an EU-funded project that aims to assess the value of personalised breast cancer screening for women aged 40 to 70 in Europe and Israel.

New scientific data suggest that a new screening strategy, based on the estimation of individual breast cancer risk, may have a better benefit/risk ratio for all women than current standard screening.

To verify this hypothesis, a large international clinical study is being carried out. It compares current screening with a new personalised screening approach based on estimating the individual risk of developing breast cancer in the coming years.
Women who volunteer to participate in the study are randomly assigned to two groups. In the first, they follow the standard screening during the 4 years of participation in the study; in the second, they follow their personalised screening schedule, established according to their own risk of developing breast cancer.

The study is implemented in 6 countries (Belgium, France, Israel, Italy, Spain, United Kingdom) and the objective is to recruit 85,000 female volunteers. 

CPO is a project partner and coordinates the Workpackage on Communication. CPO is also conducting the trial in Turin, within the regional screening program “Prevenzione Serena”.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement N° 755394.

Learn more about the study: